17 February 2021 - New agreement brings total supply to the European Union to 500 million doses, with delivery expected by the end of 2021.
Pfizer and BioNTech today announced an agreement with the European Commission to supply an additional 200 million doses of Comirnaty, the companies’ COVID-19 Vaccine, to the 27 European Union member states.
The European Commission has the option to request supply of an additional 100 million doses.